普罗布考对不稳定型心绞痛患者血清明胶酶的影响
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
普罗布考对不稳定型心绞痛患者血清明胶酶的影响
刘春辉;贺兆发;乔峰
【期刊名称】《心血管康复医学杂志》
【年(卷),期】2011(20)6
【摘要】Objective: To investigate effects of probucol on serum levels of gelatinases in patients with unstable angina pectoris (UAP). Methods: A total of 80 UAP patients were continuously enrolled and randomly divided into probucol treatment group (n=40) and routine treatment group (n=40). Routine treatment group was given routine medical treatment with nitrates, aspirin and P-receptor blocker etc; probucol group was given probucol oral additionally based on routine treatment. Serum levels of gelatinases were examined before and one month after treatment. Results: Compared with before treatment, levels of matrix metalloproteinase (MMP) -2 [ (54. 04±6. 54) ng/ml vs. (32. 43±1. 81) ng/ml] and MMP-9 [ (56. 33±7.
25) ng/ml vs. (34 + 1. 45) ng/ml] significantly decreased in probucol treatment group after treatment (P<0. 01 both), and significantly lower than those of routine treatment group [MMP-2: (37.21 + 2.86) ng/ml, MMP-9: (39. 96±1. 75) ng/ml], P<0. 05. Conclusion: Probucol could decrease serum levels of gelatinases in patients with unstable angina pectoris, and possess effect of stabilization of atherosclerotic plaque.%目的:探讨普罗布考对不稳定型心绞痛(UAP)患者血清明胶酶的影响.方法:连续入选UAP 患者80例,随机分为普罗布考治疗组(40例)和常规治疗组(40例).常规治疗组采用
硝酸酯类、阿司匹林、β受体阻滞剂等常规药物治疗;普罗布考组在常规治疗基础上加用普罗布考口服,观察治疗前及治疗一个月后血清明胶酶水平.结果:与治疗前比较,普罗布考治疗组治疗后基质金属蛋白酶(MMP) -2[(54.04±6.54) ng/ml比(32.43±1.81) ng/ml]、MMP-9[(56.33±7.25) ng/ml比(34±1.45) ng/ml]水平均明显下降(P均<0.01),且明显低于常规治疗组治疗后[ MMP-2:(37.21±2.86)
ng/ml、MMP-9:(39.96±1.75)ng/ml],P<0.05.结论:普罗布考能促进不稳定型心绞痛患者血清明胶酶水平的下降,起到稳定粥样斑块的作用.
【总页数】3页(P549-551)
【作者】刘春辉;贺兆发;乔峰
【作者单位】佳木斯大学附属第一医院心内科,黑龙江佳木斯154002;佳木斯大学附属第一医院心内科,黑龙江佳木斯154002;佳木斯大学附属第一医院心内科,黑龙江佳木斯154002
【正文语种】中文
【中图分类】R541.4
【相关文献】
1.姜黄素对不稳定型心绞痛患者血清明胶酶水平的影响 [J], 金梅花;刘春辉;李爱歆
2.不同剂量阿托伐他汀对急性冠状动脉综合征患者血清明胶酶B水平影响的观察[J], 张素华;张利宣;赵维江;曹治宸;黄建敏;潘丽萍
3.尼可地尔联合用药对不稳定型心绞痛患者血清超敏C反应蛋白基质金属蛋白酶9淀粉样酶A及血脂水平的影响 [J], 张书军
4.普罗布考对急性冠状动脉综合征患者血清髓过氧化酶和高敏C反应蛋白的影响[J], 王立真
5.普罗布考对急性冠状动脉综合征患者血清中基质金属蛋白酶-2及基质金属蛋白酶-9水平的影响 [J], 王永维;韩敏;孟晓萍
因版权原因,仅展示原文概要,查看原文内容请购买。